| abstract |
Disclosed are a dihydropyrimidine compound and the use thereof in a drug, particularly the use thereof in a drug for treating and preventing hepatitis B. Specifically, the present invention relates to a compound as represented by general formula (I) or (Ia), or a stereoisomer, tautomer, oxynitride, solvate, metabolite, pharmaceutically acceptable salt or prodrug thereof, wherein each variable is as defined in the description. The present invention also relates to the use of the compound as represented by general formula (I) or (Ia), or an enantiomer, diastereomer, tautomer, hydrate, solvate, or pharmaceutically acceptable salt thereof in a drug, particularly the use thereof in a drug for treating and preventing hepatitis B. <img file="dest_path_image001.jpg" he="115.09" img-content="drawing" img-format="jpg" inline="yes" orientation="portrait" wi="120.65"/> |